Bench to Bedside
The Faculty of Medicine is proud to partner with the NHS in a range of key National Institute for Health Research (NIHR) designated and supported infrastructure. This portfolio of networks and partnerships supports Imperial discovery to progress across the translational pathway into clinical benefit. Some examples of the wide-range of facilities available at Imperial are featured below - for a fuller list of NIHR supported translational infrastructure and facilities which are linked with Imperial please see the 'Quick Links' list.
NIHR translational support - a sample selection
NIHR Imperial Biomedical Research Centre (BRC)
Undertaking translational research to quickly transfer the findings from basic research into healthcare improvements for patients.
NIHR Imperial BRC website
NIHR Respiratory Disease Biomedical Research Unit (BRU)
The NIHR Respiratory Disease BRU incorporates clinical research facilities for adult inpatient and adult and paediatric outpatient trials.
NIHR Cardiovascular Disease Biomedical Research Unit (BRU)
The NIHR Cardiovascular Disease BRU incorporates state-of-the-art facilities for cardiac imaging, interventional cardiology and genetics.
HPRUs, DEC, welcome crf
NIHR-Wellcome Trust Imperial Clinical Research Facility
The Imperial Clinical Research Facility (CRF) is funded by the National Institute of Health Research to support experimental medicine studies (investigations in humans) to identify the cause of disease and/or to test the validity and importance of new discoveries and treatments. The facility provides support and state of the art inpatient and outpatient clinical trials facilities which are available for AHSC staff as well external researchers and commercial companies.
NIHR-Wellcome Trust Imperial CRF
NIHR/PHE Health Protection Research Units
Imperial hosts or partners in four NIHR/PHE Health Protection Research Units (HPRUs) -part of a major joint investment by the National Institute for Health Research and Public Health England (PHE) to create centres of excellence in multi-disciplinary health protection research in 2014. The Imperial HPRUs represent four from a total of 13 successful applications across a total of 12 priority public health areas.
Healthcare Associated Infections and Antimicrobial Resistance
Health Impact of Environmental Hazards (led by Kings College London)
NIHR Diagnostic Evidence Cooperative
The National Institute of Health Research Diagnostic Evidence Cooperatives (NIHR-DEC) at Imperial is one of four NIHR funded organisations that look at the way a number of different diseases are diagnosed, so patients can access the best available treatments more quickly. The primary aim of Imperial DEC is to develop a system for evidence generation and integration of Point Of Care-in vitro diagnostic devices (POC-IVD) into clinical practice, by forming close partnerships with doctors, scientists, patients, industry, regulatory bodies and the NHS.